BioTryp Therapeutics is developing a class of small molecules that inhibit biofilm formation, targeting bacterial infections, particularly urinary tract infections (UTIs)
BioTryp Therapeutics is developing a class of small molecules that inhibit biofilm formation, targeting bacterial infections, particularly urinary tract infections (UTIs). Their technology aims to provide an alternative to traditional antibiotic treatments by preventing the recurrence of hard-to-treat infections.